NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 239 filers reported holding NEKTAR THERAPEUTICS in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,113 | -98.9% | 492,500 | +1486.2% | 0.02% | +1500.0% |
| Q3 2022 | $99,000 | -95.6% | 31,049 | -92.5% | 0.00% | -96.4% |
| Q1 2022 | $2,241,000 | +694.7% | 415,709 | +1890.6% | 0.03% | +833.3% |
| Q4 2021 | $282,000 | -72.3% | 20,884 | -63.2% | 0.00% | -78.6% |
| Q3 2021 | $1,019,000 | +38.3% | 56,756 | +32.1% | 0.01% | +75.0% |
| Q2 2021 | $737,000 | +162.3% | 42,964 | +159.7% | 0.01% | +166.7% |
| Q4 2020 | $281,000 | -66.5% | 16,544 | -67.2% | 0.00% | -82.4% |
| Q3 2020 | $838,000 | +1.7% | 50,503 | +42.0% | 0.02% | -19.0% |
| Q2 2020 | $824,000 | -7.5% | 35,558 | -13.9% | 0.02% | +23.5% |
| Q4 2019 | $891,000 | – | 41,279 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
| GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
| Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
| Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
| Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
| CM Management, LLC | 50,000 | $160,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
| PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
| Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |
| ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |